Oragenics Statistics
Total Valuation
Oragenics has a market cap or net worth of $1.10 million. The enterprise value is $260,717.
Important Dates
The next estimated earnings date is Friday, August 8, 2025, after market close.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Oragenics has 822,927 shares outstanding. The number of shares has increased by 293.31% in one year.
| Current Share Class | 822,927 |
| Shares Outstanding | 822,927 |
| Shares Change (YoY) | +293.31% |
| Shares Change (QoQ) | +52.87% |
| Owned by Insiders (%) | 2.06% |
| Owned by Institutions (%) | 4.42% |
| Float | 723,291 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.33 |
| P/TBV Ratio | 8.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 18.55.
| Current Ratio | 1.04 |
| Quick Ratio | 0.92 |
| Debt / Equity | 18.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.63 |
Financial Efficiency
Return on equity (ROE) is -748.05% and return on invested capital (ROIC) is -232.47%.
| Return on Equity (ROE) | -748.05% |
| Return on Assets (ROA) | -170.96% |
| Return on Invested Capital (ROIC) | -232.47% |
| Return on Capital Employed (ROCE) | -7,353.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.07M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.96% in the last 52 weeks. The beta is 0.95, so Oragenics's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | -95.96% |
| 50-Day Moving Average | 4.08 |
| 200-Day Moving Average | 7.76 |
| Relative Strength Index (RSI) | 26.56 |
| Average Volume (20 Days) | 1,190,439 |
Short Selling Information
The latest short interest is 289,544, so 35.18% of the outstanding shares have been sold short.
| Short Interest | 289,544 |
| Short Previous Month | 29,708 |
| Short % of Shares Out | 35.18% |
| Short % of Float | 40.03% |
| Short Ratio (days to cover) | 0.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | -3.79M |
| Operating Income | -10.12M |
| Pretax Income | -19.52M |
| Net Income | -10.33M |
| EBITDA | n/a |
| EBIT | -10.12M |
| Earnings Per Share (EPS) | -$30.10 |
Full Income StatementBalance Sheet
The company has $3.42 million in cash and $2.55 million in debt, giving a net cash position of $866,693 or $1.05 per share.
| Cash & Cash Equivalents | 3.42M |
| Total Debt | 2.55M |
| Net Cash | 866,693 |
| Net Cash Per Share | $1.05 |
| Equity (Book Value) | 137,688 |
| Book Value Per Share | 0.19 |
| Working Capital | 137,688 |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.65M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.65M |
| FCF Per Share | -$9.29 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
